Advertisement

HIV Physicians and Chronic Opioid Therapy: It’s Time to Raise the Bar

  • Jennifer J. Carroll
  • Jonathan Colasanti
  • Marlene C. Lira
  • Carlos del Rio
  • Jeffrey H. Samet
Original Paper

Abstract

Clinical practice that utilizes chronic opioid therapy has been recognized as one major cause of the opioid crisis. Among patients living with HIV, the risks associated with chronic opioid therapy may be complicated by factors such as co-occurring mental health diagnoses, substance use, and economic marginalization. Improving opioid prescribing practices in HIV clinics requires attention to these and other characteristics common to HIV care. In the context of a randomized controlled trial testing an intervention to improve opioid prescribing practices in HIV outpatient clinics, we interviewed physicians about their perspectives on chronic opioid therapy. Overwhelmingly, physicians voiced ambivalence about their own knowledge and comfort with prescription opioids. They raised concerns about the impact of opioid prescribing on patient-provider relationships and the increasing workload associated with prescribing and monitoring patients. In this report, we explore these concerns and propose several strategies for improving clinical care in which chronic opioid therapy is addressed.

Keywords

HIV Opioids Pain Safety Prescribing 

Notes

Acknowledgement

This work was supported by the National Institutes of Health/National Institutes of Drug Abuse [R01DA037768 to J.H.S and C.d.R.]. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute on Drug Abuse or the National Institutes of Health.

Compliance with Ethical Standards

Conflicts of interest

All authors declare that they have no conflicts of interest.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed Consent

Informed consent was obtained from all individual participants included in this study.

References

  1. 1.
    Ahmad F, Rossen L, Spencer M, Warner M, Sutton P. Provisional drug overdose data [Internet]. National Center or Health Statistics; 2018. Available from: https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm.
  2. 2.
    Mars SG, Bourgois P, Karandinos G, Montero F, Ciccarone D. “Every ‘never’ I ever said came true”: transitions from opioid pills to heroin injecting. Int J Drug Policy. 2014;25(2):257–66.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Ciccarone D. Editorial for “US Heroin in Transition: Supply Changes, Fentanyl Adulteration and Consequences” IJDP special section. Int J Drug Policy. 2017;46:107–11.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Rummans TA, Burton MC, Dawson NL. How good intentions contributed to bad outcomes: the opioid crisis. Mayo Clin Proc. 2018;93(3):344–50.CrossRefPubMedGoogle Scholar
  5. 5.
    Uebelacker LA, Weisberg RB, Herman DS, Bailey GL, Pinkston-Camp MM, Stein MD. Chronic pain in HIV-infected patients: relationship to depression, substance use, and mental health and pain treatment. Pain Med Malden Mass. 2015;16(10):1870–81.CrossRefGoogle Scholar
  6. 6.
    Colasanti J, Lira MC, Cheng DM, Liebschutz JM, Tsui JI, Forman LS, et al. Chronic opioid therapy in HIV-infected patients: patients’ perspectives on risks. Monitoring and Guidelines: Clin Infect Dis; 2018.Google Scholar
  7. 7.
    Arentoft A, Byrd D, Monzones J, Coulehan K, Fuentes A, Rosario A, et al. Socioeconomic status and neuropsychological functioning: associations in an ethnically diverse HIV+ cohort. Clin Neuropsychol. 2015;29(2):232–54.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Sionean C, Le BC, Hageman K, Oster AM, Wejnert C, Hess KL, et al. HIV Risk, prevention, and testing behaviors among heterosexuals at increased risk for HIV infection–National HIV Behavioral Surveillance System, 21 U.S. cities, 2010. Morb Mortal Wkly Rep Surveill Summ Wash DC 2002. Morb Mortal Wkly Rep Surveill Summ. 2002;63(14):1–39.Google Scholar
  9. 9.
    Merlin JS, Walcott M, Kerns R, Bair MJ, Burgio KL, Turan JM. Pain self-management in HIV-infected individuals with chronic pain: a qualitative study. Pain Med Malden Mass. 2015;16(4):706–14.CrossRefGoogle Scholar
  10. 10.
    Hansen L, Penko J, Guzman D, Bangsberg DR, Miaskowski C, Kushel MB. Aberrant behaviors with prescription opioids and problem drug use history in a community-based cohort of HIV-infected individuals. J Pain Symptom Manag. 2011;42(6):893–902.CrossRefGoogle Scholar
  11. 11.
    Namisango E, Harding R, Atuhaire L, Ddungu H, Katabira E, Muwanika FR, et al. Pain among ambulatory HIV/AIDS patients: multicenter study of prevalence, intensity, associated factors, and effect. J Pain Off J Am Pain Soc. 2012;13(7):704–13.CrossRefGoogle Scholar
  12. 12.
    Merlin JS, Zinski A, Norton WE, Ritchie CS, Saag MS, Mugavero MJ, et al. A conceptual framework for understanding chronic pain in patients with HIV. Pain Pract. 2014;14(3):207–16.CrossRefPubMedGoogle Scholar
  13. 13.
    Lum PJ, Little S, Botsko M, Hersh D, Thawley RE, Egan JE, et al. Opioid-prescribing practices and provider confidence recognizing opioid analgesic abuse in HIV primary care settings. J Acquir Immune Defic Syndr. 2011;56(1):S91–7.CrossRefPubMedGoogle Scholar
  14. 14.
    Tsui JI, Walley AY, Lira MC, Chaisson CE, Forman LS, Colasanti JA, et al. Opioid Prescribing Attitudes and Risk Mitigation Practices in Two HIV Clinics. Conference presentation presented at: Annual Meeting of the College on Problems of Drug Dependence; 2017; Montreal.Google Scholar
  15. 15.
    Liebschutz JM, Xuan Z, Shanahan CW, LaRochelle M, Keosaian J, Beers D, et al. Improving adherence to long-term opioid therapy guidelines to reduce opioid misuse in primary care: a cluster-randomized clinical trial. JAMA Intern Med. 2017.Google Scholar
  16. 16.
    Bauer SR, Katz MH. Going beyond guideline-concordant opioid therapy to improve patient safety. JAMA Intern Med. 2017;177(9):1272.CrossRefPubMedGoogle Scholar
  17. 17.
    Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain-United States, 2016. JAMA. 2016;315(15):1624–45.CrossRefGoogle Scholar
  18. 18.
    Avorn J. Academic detailing: “Marketing” the best evidence to clinicians. JAMA. 2017;317(4):361–2.CrossRefPubMedGoogle Scholar
  19. 19.
    Bruce RD, Merlin J, Lum PJ, Ahmed E, Alexander C, Corbett AH, et al. 2017 HIVMA of IDSA clinical practice guideline for the management of chronic pain in patients living with HIV. Clin Infect Dis. 2017;65(10):e1–37.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Katzman JG, Galloway K, Olivas C, McCoy-Stafford K, Duhigg D, Comerci G, et al. Expanding health care access through education: dissemination and implementation of the ECHO model. Mil Med. 2016;181(3):227–35.CrossRefPubMedGoogle Scholar
  21. 21.
    Weinstein RS, Lopez AM, Joseph BA, Erps KA, Holcomb M, Barker GP, et al. Telemedicine, telehealth, and mobile health applications that work: opportunities and barriers. Am J Med. 2014;127(3):183–7.CrossRefPubMedGoogle Scholar
  22. 22.
    Starrels JL, Peyser D, Haughton L, Fox A, Merlin JS, Arnsten JH, et al. When human immunodeficiency virus (HIV) treatment goals conflict with guideline-based opioid prescribing: a qualitative study of HIV treatment providers. Subst Abuse. 2016;37(1):148–53.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Jennifer J. Carroll
    • 1
    • 2
  • Jonathan Colasanti
    • 3
    • 4
  • Marlene C. Lira
    • 5
  • Carlos del Rio
    • 3
    • 4
  • Jeffrey H. Samet
    • 5
    • 6
  1. 1.Department of MedicineBrown UniversityProvidenceUSA
  2. 2.Department of Sociology and AnthropologyElon UniversityElonUSA
  3. 3.Division of Infectious DiseasesEmory UniversityAtlantaUSA
  4. 4.Hubert Department of Global Health, Rollins School of Public HealthEmory UniversityAtlantaUSA
  5. 5.Clinical Addiction Research and Education (CARE) Unit, Section of General Internal Medicine, Department of MedicineBoston Medical CenterBostonUSA
  6. 6.Department of Community Health SciencesBoston University School of Public HealthBostonUSA

Personalised recommendations